Manulife (Manufacturers Life Insurance)
AVIR icon

Manulife (Manufacturers Life Insurance)’s Atea Pharmaceuticals AVIR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Sell
20,172
-3,795
-16% -$17.4K ﹤0.01% 2605
2025
Q4 		$85.6K Sell
23,967
-6,136
-20% -$19.5K ﹤0.01% 2739
2025
Q3 		$87.3K Sell
30,103
-2,638
-8% -$9.01K ﹤0.01% 2802
2025
Q2 		$118K Buy
32,741
+2,172
+7% +$6.48K ﹤0.01% 2728
2025
Q1 		$91.4K Sell
30,569
-1,772
-5% -$5.53K ﹤0.01% 2714
2024
Q4 		$108K Sell
32,341
-1,213
-4% -$4.03K ﹤0.01% 2802
2024
Q3 		$112K Sell
33,554
-1,332
-4% -$4.83K ﹤0.01% 2836
2024
Q2 		$115K Buy
34,886
+4,339
+14% +$16.2K ﹤0.01% 2788
2024
Q1 		$123K Sell
30,547
-2,438
-7% -$9.54K ﹤0.01% 2731
2023
Q4 		$101K Hold
32,985
– – ﹤0.01% 2817
2023
Q3 		$99K Buy
32,985
+46
+0.1% +$157 ﹤0.01% 2812
2023
Q2 		$123K Buy
32,939
+2,532
+8% +$9.48K ﹤0.01% 2768
2023
Q1 		$102K Sell
30,407
-189,700
-86% -$770K ﹤0.01% 2740
2022
Q4 		$1.06M Buy
220,107
+310
+0.1% +$1.57K ﹤0.01% 1580
2022
Q3 		$1.25M Sell
219,797
-511
-0.2% -$3.91K ﹤0.01% 1516
2022
Q2 		$1.56M Sell
220,308
-38,347
-15% -$262K ﹤0.01% 1482
2022
Q1 		$1.86M Buy
258,655
+35,000
+16% +$238K ﹤0.01% 1529
2021
Q4 		$2.01K Sell
223,655
-59,768
-21% -$931K ﹤0.01% 1497
2021
Q3 		$9.94M Sell
283,423
-3,417
-1% -$94.8K 0.01% 934
2021
Q2 		$6.16M Buy
286,840
+27,364
+11% +$822K 0.01% 1180
2021
Q1 		$16M Buy
259,476
+1,191
+0.5% +$80.5K 0.01% 750
2020
Q4 		$10.8M Buy
+258,285
New +$8.33M 0.01% 859

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AVIR Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Atea Pharmaceuticals (AVIR) stake by 16% in Q1 2026, selling an estimated $17.4K and leaving 20,172 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #2605.

Manulife (Manufacturers Life Insurance) first reported a position in AVIR in Q4 2020 and has held it in 22 quarters since. The position peaked at $16M in Q1 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 20,172 shares of Atea Pharmaceuticals worth $109K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 3,795 Atea Pharmaceuticals shares in Q1 2026, an estimated $17.4K.
  • Atea Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2605 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Atea Pharmaceuticals position peaked at $16M in Q1 2021.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.